Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: Italy Clear all

175 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20023
20033
20044
20058
200610
200712
200811
20099
20104
20118
20129
20136
201410
201512
20168
20178
20184
20196
20208
20214
20223
20235
20245
20257
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed96
Terminated28
Unknown status18
Recruiting15
Active, not recruiting12
Withdrawn5
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche19
Novartis Pharmaceuticals9
Pfizer9
European Institute of Oncology8
Bayer7
Eli Lilly and Company7
GlaxoSmithKline7
MedSIR7
Consorzio Oncotech6
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms175
Neoplasm Metastasis16
Triple Negative Breast Neoplasms10
Neoplasms9
Carcinoma, Non-Small-Cell Lung7
Brain Neoplasms6
Colorectal Neoplasms5
Melanoma5
Ovarian Neoplasms5
Biliary Tract Neoplasms4

Trials

Showing 1 to 25 of 175. Each trial links to its page on Pharma Observatory.

75 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.